Atrial fibrillation (AF) affects more than 3.5 million Americans and is a major source of strokes and a precursor to ...
May 13, 2008 - Boston Scientific reported that the FDA cleared its COGNIS cardiac resynchronization therapy ...
May 14, 2008 - A randomized controlled trial conducted by Brigham and Women's Hospital in affiliation with Harvard ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The most “wired” cardiology departments integrate IT systems, leverage data tracking and patient monitoring solutions, optimize data and image management for improved workflow, consult evidence-based medicine and plan for future enhancements to their infrastructure.
Boston Scientific has expanded its portfolio with COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN implantable cardioverter defibrillator (ICD), new platforms to treat heart failure and sudden cardiac death.
May 14, 2008 - Siemens Healthcare will extend its strategic alliance with Biosense Webster by opening up the ACUSON ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Efforts to reduce discovery-to-balloon (d-to-b) and door-to-balloon times is sweeping the country as hospitals put in ...
May 14, 2008 - St. Jude Medical received both FDA 510(k) clearance and European CE Mark approvals of the IsoFlex Optim ...
The FDA cleared for marketing a new automated version of diaDexus’ proprietary PLAC Test, an automated immunoassay designed to run on common existing laboratory equipment, including clinical chemistry analyzers from Hitachi, Roche/Hitachi and Olympus, expanding the number of clinical labs and physician offices that are able to offer the PLAC Test.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
TomTec Imaging Systems recently announced that its new CardioArena, the network and imaging solution for cardiology ...
May 13, 2008 - Medtronic received FDA premarket approval (PMA) for the first wave of cardiac rhythm disease management ...
Northeast Monitoring received clearance from the FDA to sell its DR200 Series devices with its automatic atrial ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Boston Scientific Corp. said the FDA approved three products in its Cardiac Rhythm Management business, including the ...
May 13, 2008 – The FDA approved changes to the U.S. product label for DEFINITY Vial For (Perflutren Lipid Microsphere) ...
Boston Scientific’s IQ Guidewire is designed to provide the torque response, side branch access support and device ...